At a Glance
| Detail | Antidote | Clio |
|---|---|---|
| Category | Practice Mgmt | Practice Mgmt |
| Total raised | $5M | $1.79B |
| Rounds tracked | 1 | 6 |
| Latest round | Seed, $5M · Jan 2026 | Series G, $500M · Nov 2025 |
| Last valuation | Not disclosed | $5B |
| Lead investors | Lakestar | New Enterprise Associates, TCV, JMI Equity, T. Rowe Price |
| Built for | Large firms | Mid-size firms, Boutiques |
| Headquarters | United Kingdom | Canada |
Funding, Side by Side
Antidote rounds
- Jan 2026Seed$5M
Clio rounds
- Nov 2025Series G$500M
- Jul 2024Series F$900M
- Apr 2021Series E$110M
- Sep 2019Series D$250M
- Mar 2014Series C$20M
- Jan 2012Series B$6M
Our Take
We have not tested these two head to head yet. The numbers above come from public funding announcements. If you use either one, tell us what you found and it may become a Field Note.
Quick Answers
- Which has raised more, Antidote or Clio?
- Clio has raised $1.79B in disclosed funding, compared with $5M for Antidote.
- Do Antidote and Clio share investors?
- No. None of the investors we track have backed both companies.
- What is Antidote best for?
- Antidote is AI billing compliance software that checks and corrects law firm time entries against client billing guidelines.
- What is Clio best for?
- Clio is cloud legal practice management software for case management, time tracking, billing and client intake at law firms.
Source: Legal Tech Circle funding data, from public announcements. Updated November 10, 2026.